The Efficacy Of Anlotinib In Squamous Cell Carcinoma (Scc) Patients With Or Without Hypertension In Alter0303: Anlotinib As A Third-Line Therapy In Patients With Advanced Non-Small Cell Lung Cancer (Nsclc).
JOURNAL OF CLINICAL ONCOLOGY(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要